J4 ›› 2009, Vol. 35 ›› Issue (4): 702-705.

• 临床研究 • 上一篇    下一篇

注射用心肌肽在体外循环心内直视手术期间对患者心肌缺血再灌注损伤的保护作用

吕民1, 张柏民1, 李惠君2, 张秀和1, 姜亦忠1   

  1. 1.吉林大学中日联谊医院心血管外科|吉林 长春 130033; |2.中国医学科学院阜外心血管病医院心血管外科|北京 100037
  • 收稿日期:2009-01-07 出版日期:2009-07-28 发布日期:2009-08-24
  • 通讯作者: 张柏民 E-mail:zhangbaimin@sina.com
  • 作者简介:吕 民(1969-)|男|吉林省长春市人|副教授|医学硕士|主要从事心肌保护方面的研究。
  • 基金资助:

     吉林省科技厅科技发展计划项目资助课题(20030420-01)
     
     

 Myocardium protection of cardiomyopeptide for injection against ischemia-reperfusion injury during open heart surgery with cardiopulmonary bypass

 LV Min1, ZHANG Bai-Min1, LI Hui-Jun2, ZHANG Xiu-He1, JIANG Yi-Zhong1   

  1. 1.Department of Cardiovascular Surgery|China-Japan Union Hospital,Jilin University,Changchun 130033,China;2.Department of Cardiovascular Surgery,Cardiovascular Institute and Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China
  • Received:2009-01-07 Online:2009-07-28 Published:2009-08-24

摘要:

目的:通过观察注射用心肌肽在体外循环(CPB)心内直视手术期间的应用,阐明其对患者心肌再灌注损伤的防护作用。方法: 30例二尖瓣机械瓣置换患者,采用随机数字表方法分为实验组和对照组。实验组在术中及术后,给予注射用心肌肽。两组患者分别在体外转流前(T0)、主动脉开放即刻(T1)、主动脉开放后30 min(T2)、停止CPB 12 h(T3)、24 h(T4)抽取桡动脉血,检测肌酸激酶同功酶(CK-MB)、心肌肌钙蛋白I(cTnI)、血浆肿瘤坏死因α(TNF-α)的浓度。术后第7天测心脏射血分数(EF)。结果 :两组患者体外转流前血浆CK-MB、cTnI 及TNF-α浓度比较差异无显著性(P>0.05);开放30 min后两组患者血清CK-MB、TNF-α明显高于T1(P<0.05),且实验组在T2、T3、T4各相同时间点血清CK-MB、TNF-α浓度均明显低于对照组(P<0.05);主动脉开放即刻两组患者血清cTnI明显升高,且实验组在T1、T2、T3、T4各相同时间点血清cTnI明显低于对照组(P<0.05)。术后7 d,实验组EF值明显高于对照组(P<0.05)。结论:在CPB心内直视手术术中及术后给予注射用心肌肽可明显减轻炎症反应、抑制心肌损伤,改善心功能。

关键词: 心肌肽;体外循环;心肌保护;缺血再灌注损伤

Abstract:

Objective To investigate the myocardium protection of  cardiomyopeptide for injection against ischemia-reperfusion injury  during open heart surgery withcardiopulmonary bypass(CPB).Methods Thirty patients scheduled for elective cardiac valvular replacement were divided into two groups.In treatment group (n=15),
 cardiomyopeptide for injection  was used during CPB;but in control group (n=15),no cardiomyopeptide for injection was used.Blood samples were drawn from the radial artery at the following time points: before CPB(T0);at release of aortic declamping(T1);30 min after aortic declamping(T2);12 h after aortic declamping(T3);24 h after aortic declamping(T4).The levels of creatine phosphokinase isoenzyme(CK-MB),cardiac troponin I(cTnI) in plasma  were measured.Enzyme-linked immunosorbent assays (ELISA) was used to measure the concentration of tumor necrosis factor-a (TNF-a)in plasma.Ejection fraction(EF) was measured at the 7th day after operation.Results The levels of CK-MB,cTnI,and TNF-α in plasma in two groups showed no difference before CPB(P>0.05).The levels of CK-MB and TNF-α in two groups were  significantly increased30 min after aortic declamping than  release of aortic declamping (P<0.05).The levels of CK-MB and TNF-α in plasma in treatment group were significantly lower than those in control group 30 min,12 h and 24 h after aortic declamping(P<0.05).The plasma concentrations of cTnI in two groups were  significantly increased at release of aortic declamping (P<0.05).The concentrations of cTnI in treatment group were significantly lower than those in  control group at T1,T2,T3,T4(P<0.05).EF in treatment group  was significantly higher than that in  control group at the 7th day after operation(P<0.05).Conclusion Cardiomyopeptide for injection can  protect myocardium and reduce the acute inflammatory response during CPB and improve heart function after operation.
 

Key words: cardiomyopeptide;cardiopulmonary bypass;myocardium protection;ischemia-reperfusion injury

中图分类号: 

  • R654.1